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Expression of J chain mRNA in duodenal IgA plasma cells in IgA
nephropathy. Glomerular IgA in IgA nephropathy (IgAN) is at least in
part polymeric, and is thought to derive from the mucosal IgA system
in view of the association between mucosal infection and haematuria in
this condition. To investigate this hypothesis, an in situ hybridization
(ISH) technique was developed for the detection of J chain mRNA, the
expression of which has been correlated with the secretion of high level
polymeric immunoglobulin (pIg). Endoscopic duodenal biopsies from
ten patients and matched controls were examined by: (i) two color
immunofluorescence (IF); (ii) ISH; and (iii) combined ISH and IF, to
permit simultaneous identification of plasma cell type. IF revealed a
reduction in the percentage of IgA plasma cells (P < 0.02) and increased
absolute numbers of IgG cells (P < 0.02) in patient biopsies. ISH
demonstrated fewer J chain mRNA expressing plasma cells (P < 0.005)
with lower signal intensity (P < 0.002) in patients' biopsies compared
with controls. Combined ISH and IF confirmed a reduction in J chain
mRNA-positive IgA plasma cells in the patient biopsies (P < 0.02). The
reduction in J chain mRNA expression in duodenal IgA plasma cells in
IgAN argues against the gastrointestinal lamina propria as the source of
glomerular pIgA.
IgAN is the most prevalent form of glomerulonephritis in the
Western world [1]. Approximately one-third of patients progress
to end-stage renal failure [2]. The pathological hallmark of the
condition is the predominant deposition of IgA in the glomeru-
lar mesangium [3]. Although the molecular nature of deposited
IgA is controversial the balance of evidence suggests that it is,
at least in part, polymeric (pIgA), since it contains J chain [4, 5]
and has the capacity to bind secretory component [4, 6]. Renal
biopsy elution studies also substantiate the polymeric nature of
mesangial IgA [5, 71. The source of the glomerular IgA remains
unknown although strong circumstantial evidence points to the
mucosal IgA immune system—the main source of pIgA. Many
patients with IgAN experience episodic macroscopic hematuria
[8] which may be spontaneous or coincide with mucosal infec-
tion, usually of the respiratory or gastrointestinal tracts. In-
creased circulating pIgA is found during such relapses [9—11]. A
mucosal origin for glomerular IgA in IgAN is also suggested by
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increased levels of circulating IgA antibodies to food antigens
and common respiratory and gastrointestinal pathogens [12—
16], the presence of food antigens in association with glomeru-
lar IgA deposits also supports this view [17]. It has therefore
been proposed that IgAN results from a poorly controlled
mucosal immune response to environmental antigens, and that
excess mucosally generated pIgA gains access to the circulation
and becomes trapped in the mesangium [2, 18, 19].
Studies of a variety of human lymphoid tissues have reported
abnormalities in IgA plasma cell count in IgAN [20—25], IgA cell
counts, however, may not be relevant to the rate of pIgA
production. Few studies have addressed the important question
of J chain expression [22, 24].
J chain is the key to mucosal IgA secretory immunity as it is
integral to the synthesis of functional pigA. Although some
studies have demonstrated that polymers may form in vitro in
the absence of J chain [26, 27], other work suggests that J chain
plays a crucial role in normal immunoglobulin polymerization
[28—31] and secretion [32, 331. It is also essential for transcel-
lular transport to luminal surfaces, where polymeric Ig is in the
front line of mucosal defence [34, 35]. The production of J chain
is not controlled at the level of translation [28], but rather at the
level of transcription [36]. Increases in pIg secretion have been
shown to parallel rises in J chain mRNA [37] and an in vitro
analysis of 1gM production has revealed that the appearance of
mRNA for J chain is a limiting factor in high level polymeric Ig
secretion [321.
Some investigators have studied the expression of J chain in
the tonsils of patients with IgAN using purely immunological
techniques [22, 24], none has investigated J chain expression
within the lamina propria, which is the main effector site of the
mucosal IgA immune system. Evidence of tncreased J chain
expression by mucosal IgA plasma cells would therefore pro-
vide strong support for the view that excess circulating pIgA
and deposited glomerular pigA are mucosally derived in IgAN.
Adequate investigation in this area has previously been
hampered by the lack of readily available reliable anti-J chain
antibodies, the relative inaccessibility of J chain within polymer
structures, the difficulty of sample collection, and the absence
of established techniques for the investigation of J chain gene
expression within human lymphoid tissue.
We have developed an in situ hybridization technique which
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allows the detection of native mRNA species within plasma
cells of a known isotype in routine pathology specimens. This
method allows investigation of pigA production in the gastro-
intestinal mucosa and elsewhere in IgAN, by studying J chain
gene expression in individual IgA plasma cells.
Methods
Subjects
Endoscopic biopsies from the second part of the duodenum
were obtained from ten patients with renal biopsy-proven IgAN
who had no symptoms suggestive of gastrointestinal disease, (8
male, 2 female; mean age 47.8 years, range 32 to 62 years).
Control biopsies were obtained in a similar manner from ten
sex- and age-matched controls (mean age 49 years, range 36 to
65 years). Controls were individuals undergoing upper gastro-
intestinal tract evaluation in whom gastric and duodenal muco-
sae appeared macroscopically normal, and in which subsequent
microscopic examination was also normal. No patient or con-
trol was receiving H2 receptor blocking drugs or other agents
known to interfere with mucosal function. No gastrointestinal
pathology was identified in any control. Mean serum creatinine
in the IgAN group was 121.4 mol/liter (range 66 to 324
prnollliter) and only two patients had serum creatinine raised
above the reference range (170 and 324 molIliter, respective-
ly). Three patients had reported macroscopic hematuria at some
stage in their illness; however none had mucosal infection or
macroscopic hematuria at the time of study, although 6 of 10
had microscopic hematuria and 4 of 10 had proteinuria. None
was nephrotic. Although two individuals in the IgAN group had
signs of mild gastro-esophageal reflux, they were asymptom-
atic. Endoscopies were performed entirely as part of the
research protocol for this study with local ethical committee
approval.
Two-color immunofluorescence
Endoscopic biopsy specimens were fixed in formol saline for
24 hours, then processed and embedded in paraffin wax as for
routine histology. All samples were fixed and processed in the
same manner. Four micrometer tissue sections were cut onto 3-
aminopropyltriethoxysilane coated slides, and after drying
overnight at 37°C sections were dewaxed using xylene and
rehydrated through ethanol and ultra-pure water. Slides were
immersed in 50 mrs Tris-HC1 buffer, pH 7.65, (Tris-HCI), then
underwent proteolytic digestion with proteinase K (Boehringer
Mannheim, Germany, 161519) in Tris-HC1, at a concentration
of 2 tgIml for one hour at 37°C. Sections were then washed in
Tris-HCI and sequentially incubated with: (i) primary fluores-
cein isothiocyanate (FITC) labeled antibody for 30 minutes at
room temperature [anti-IgA (Dako U.K. F3 16) 1:20, anti-IgG
(Dako U.K. F315) 1:20, anti-IgM (Dako U.K. F3l7) 1:20 or
unlabeled monoclonal anti-IgA1 (Unipath U.K. M1201 1)1:101;
(ii) secondary antibody for 30 minutes at RT [tetramethyl-
rhodamine isothiocyanate (TRITC) labeled anti-heavy and
light-chain antibody (Dako U.K. R320) 1:50 or FITC labeled
rabbit anti-mouse antibody (Dako U.K. Z259) 1:10]; (iii) tertiary
antibody for IgA subclass study [TRITC labeled anti-IgA (Dako
U.K. R153) 1:50 for 7 minutes at room temperature]. Interven-
ing washes were with Tris-HCI. Antibodies were diluted in
Tris-HC1.
In situ hybridization
The in situ hybridization protocol for the detection of mRNA
for immunoglobulin J chain and kappa light chain is fully
described in a recent publication [38] and is adapted from
previously documented methods [39, 40].
In summary, fixation, processing, dewaxing, rehydration and
proteolytic digestion with proteinase K was performed as above
using RNAse free solutions and glassware. RNAse pretreat-
ment and "no hybridization" (probe omitted from hybridization
solution) controls were run in parallel with the experimental
slides. Hybridization was performed overnight at 37°C using
digoxigenin labeled deoxyoligonucleotide probe cocktails.
Probe concentrations of 200 pg/pi and 500 pg/pi were used for
J chain and kappa light chain probes, respectively. Hybrids
were detected using an alkaline phosphatase labeled sheep
polyclonal anti-digoxigenin antibody. The detection sensitivity
of labeled probe with this system was 100 fg/s1 probe solution.
Alkaline phosphatase was visualized with Fast red/naphthol
AS-MX phosphate.
Combined in situ hybridization and immunofluorescence
The simultaneous demonstration of cytoplasmic immuno-
globulin and native mRNA expression was achieved by joint
incubation of the specimens with both an FITC labeled anti-
human IgA antibody and the anti-digoxigenin antibody at the
detection stage. The use of naphthol AS-MX phosphate in the
demonstration solution produces a reaction product that is
visible in bright field illumination and under ultraviolet (UV), at
both 490 and 540 nm [41]. Hence both fluorochromes, the Fast
red/naphthol phosphate product (mRNA) and FITC (immuno-
globulin isotype) can be visualized together at 490 nm. Simul-
taneous visualization is illustrated in Figure 1. Figures 1A and
lB are the same field photographed sequentially under bright
field illumination (Fig. 1A) and then UV (Fig. 1B). In Figure 1A
cells expressing J chain mRNA have red cytoplasm (cells 1 and
2). Cells negative for J chain mRNA have a clear cytoplasm
(cell 3). On viewing under UV (490 nm) J chain mRNA
expressing cells which are negative for IgA (presumably 1gM or
IgG cells) appear red/orange (cell 1), IgA plasma cells negative
for J chain mRNA appear green (cell 3), and the combined
signal from IgA cells expressing J chain mRNA results in yellow
fluorescence (cell 2) [38].
Probe labeling
The details of probe labeling are published elsewhere [38].
Cocktails of phosphoramidite deoxyoligonucleotides [42] were
3' end labeled with the nonradioactive nucleotide analogue
digoxigenin-1 1-deoxyuridine triphosphate using terminal de-
oxynucleotidyl transferase. Deoxyoligonucleotide design was
based on previously published gene sequence data [43—46]. A
cocktail of twelve oligonucleotides was used, each 30 bases in
length. This length of oligonucleotide has been established as a
practical compromise between hybrid stability, hybrid specific-
ity, cost of synthesis and purification and tissue penetration
efficiency [39].
Controls and experimental design
"No hybridization" and RNAse pretreatment controls were
used for each specimen. Each specimen was also "probed" for
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Fig. 1. Simultaneous in situ hybridization and immunoglobulin detection by conventional immunofluorescence. (A) In situ hybridization for
immunoglobulin J chain mRNA. Bright field illumination. Hybrids were visualized with Fast red. Mayer's hematoxylin counterstain. Cells 1 and
2 are J chain mRNA positive, cell 3 is J chain mRNA negative. (B) The same field as in A but viewed under ultraviolet (490 nm). Combined J chain
mRNA signal (red) and immunofluorescence for cytoplasmic IgA (green). Cell 1, J chain mRNA positive, IgA negative; cell 2, J chain mRNA
positive, cytoplasmic IgA positive, (dual signal—yellow/ orange); cell 3, J chain mRNA negative, cytoplasmic IgA positive (x 1000). Reproduced
by permission of the Editor, Dr. J. Lilleyman of the Journal of Clinical Pathology published by the British Medical Journal Publishing Group.
Fig. 4. In situ hybridization for J chain mRNA using a digoxigenin labeled deoxyoligonucleotide probe on formol-saline fixed duodenal biopsies.
Fast red signal. Mayer's haematoxylin counterstain. (A) Control biopsy; (B) Patient biopsy (x400). Publication of these figures in color was made
possible by Bayer plc, Berkshire, United Kingdom.
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the expression of known sequences which should not have been
expressed in the tissue, namely parathormone and insulin [47,
481. These probes had a similar G-C content to the J chain probe
and acted as additional negative controls.
To assess poly-adenylated RNA preservation and determine
the optimal proteolytic digestion for each sample, preliminary
in situ hybridization studies were conducted after a range of
proteolytic digests (1 to 10 gJml) using a digoxigenin labeled
oligonucleotide poly-d(T) probe [40] and a digoxigenin labeled
deoxyoligonucleotide cocktail for kappa light chain mRNA [381.
In this way the proteolytic treatment which would render
maximum in situ signal intensity was defined for each specimen.
In situ hybridization for J chain mRNA was then conducted
after optimal proteolytic pretreatment on paired slides (patient
and matched control) running back to back, in addition to
controls as above.
To ensure that any differences between control and patient
samples were not a reflection of a nonspecific alteration in
plasma cell immunoglobulin chain mRNA expression in IgAN,
the expression of kappa light chain mRNA in lamina propria
cells was investigated by in situ hybridization alone and in
combination with immunofluorescence [38]. Hence the expres-
sion of kappa light chain mRNA in duodenal IgA plasma cells
acted as an "intracellular control" for the cells in which J chain
mRNA expression was anticipated.
Microscopy
Bright field and ultraviolet microscopy was performed using a
Nikon Optiphot microscope. Cell counts were performed on at
least 500 cells on in situ sections and 200 cells on two-color
immunofluorescent sections (counting error 3 and 9%, respec-
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Fig. 3. IgG plasma cells. Absolute numbers of IgG plasma cells per
unit area of the duodenal lamina propria in patients with IgA nephrop-
athy and controls. (0) Individual patients with serum creatinine above
the normal range.
tively) by a single observer unaware of the origin of the
specimen. IgG cells were counted per whole section since IgG
cells are very sparse within the lamina propria [49]. Absolute
numbers were therefore related to the area of lamina propria on
the specimen (measured directly from sections using an optical
planimeter). All cell enumeration was performed on sections
prior to counterstaining with Mayer's hematoxylin. Counter-
staining was performed to confirm good preservation of mor-
phology.
Confocal advanced light microscopy was performed on a
MRC600 confocal laser scanning microscope using an Argon
laser (maximum emission at 488 nm and 514 nm). Signal
intensity in individual cells was assessed by utilization of the
pixel intensity distribution facility of the microscope. Signal
intensity was assessed on 50 of the brightest cells from each
section, and the operators were unaware of the origin of each
specimen.
Statistics
Data were analyzed with the unpaired t-test and Wilcoxon
Mann-Whitney U analysis [50]. Unless stated otherwise, results
are expressed as mean standard error of mean.
Results
Immunofluorescent studies
Immunofluorescence demonstrated a reduction in IgA plasma
cells as a proportion of total plasma cells within the lamina
propria of patients (mean 85.6 1.5%) compared to controls
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Fig. 2. IgA plasma cells. Proportion of IgA plasma cells in the duode-
nal lamina propria of patients with IgA nephropathy and controls. (0)
Individual patients with serum creatinine above the normal range.
0 Control IgAN
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(mean 91 1.8%; P < 0.02; Fig. 2). In contrast, an increase in
absolute numbers of IgG plasma cells was identified in patient
biopsies (mean 13.2 l.6/l0 sq• sm) compared to controls
(mean 7.6 i.iiiO sq sm; P < 0.02; Fig. 3). There was no
significant difference between patient and control biopsies in
the proportion of 1gM plasma cells or in IgA plasma cell
subclass distribution (data not shown).
In situ hybridiation for J chain mRNA
Fast red visualized sites of hybridization were seen specifi-
cally staining the anticipated plasma cell population within the
lamina propria of duodenal biopsies from both controls and
patients. Sharp, clearly defined signal contrasted with negligible
background staining. Morphology was well preserved with all
specimens. Negative controls in which the probe was omitted
from the hybridization solution, parathormone and insulin
controls showed no signal on any occasion. RNAse Al pretreat-
ment also eliminated all signal. In contrast, pilot studies re-
vealed that DNAse pretreatment did not influence positive
results in any specimen, confirming that this method specifically
identifies the presence of RNA.
Cells expressing J chain mRNA were seen throughout the
lamina propria in control biopsies, but were maximally concen-
trated at the base of the villi (Fig. 4A). Although J chain mRNA
positive cells were identified within the patient biopsies, in a
similar distribution to that seen in the controls, the striking and
unexpected difference was a uniform reduction in cell signal
intensity (Fig. 4B). The contrast between patient and control
samples was marked; the specimens could readily be assigned
into two groups by observers unaware of the origin of each
specimen with a <5% error rate. Enumeration of positive cells
as a proportion of all cells with plasmacytoid morphology
demonstrated lower numbers of positive cells in the patient
biopsies (17 4.8%) as compared to controls (39 4.0%; P <
0.005; Fig. 5A). The fluorescent nature of the Fast red/naphthol
reaction product lends itself to examination by confocal micro-
scopy. The observed reduction in signal intensity from J chain
mRNA positive cells within patient biopsies under bright field
illumination, was semi-quantified by confocal microscopy: pa-
tients (mean pixel intensity value 54.7 3.5 a.u.) versus
controls (mean pixel intensity value 77.3 S a.u.), P < 0.002
(Fig. 6A).
In contrast, no difference in the expression of kappa light
chain mRNA between controls and patients was identified,
either in terms of positive cell enumeration or cell signal
intensity (Figs. SB and 6B).
Simultaneous in situ hybridization and immunofluorescence
Combined in situ hybridization and immunofluorescence al-
lowed the identification of the plasma cell type in which J chain
mRNA was identified. These studies revealed that in the lamina
propria of patients with IgAN there is a reduction in the
proportion of IgA plasma cells that are J chain mRNA positive
in comparison to control biopsies (control median value 95%,
patient median value 54%; P < 0.02; Fig. 7A).
No difference in the proportion of mucosal IgA plasma cells
expressing kappa light chain was evident (Fig. 7B).
There were four patients in whom no J chain mRNA could be
detected using this protocol (Figs. 5A and 7A). However, weak
positive results were obtained using higher probe concentra-
tions (400 to 600 pg/'id). There were no clinicopathological
features, including the history of macroscopic hematuria, which
distinguished these individuals from the other patients in the
IgAN group. Serum creatinine was normal in all four cases.
Discussion
In situ hybridization has advantages over other nucleic acid
assays since it allows identification of specific nucleic acid
sequences in individual cells of a tissue within their normal
topographical surroundings [51]. Our innovative adaptation of
standard non-isotopic in situ hybridization methodology [38]
allows not only a semi-quantifiable assessment of individual cell
signal intensity, but also the imrnunofluorescent identification
of the plasma cell type in which native mRNA is expressed. In
addition our experience suggests that this method may be
performed on routine or archival paraffin wax embedded mate-
rial if such material is optimally fixed initially [39].
The studies presented here demonstrate for the first time
immunoglobulin J chain gene expression by semi-quantitative
non-isotopic in situ hybridization in human duodenal tissue,
both in control and patient samples. Cells expressing J chain
mRNA were identified throughout the lamina propria in both
groups; however, they were distributed maximally as a core of
cells within the proximal two-thirds of the villi.
Our combined IF and ISH studies provide new information
concerning the J chain expression of duodenal IgA plasma cells
in IgAN. In controls the great majority of duodenal IgA cells
(median 95%) were J chain mRNA positive. These results
compare favorably with previously reported figures for J chain
expression in IgA cells of the distal ileum (derived from renal
transplant donors) using purely immunological techniques, in
which 97.3% of IgA cells were J chain positive [49]. However,
J chain mRNA expression was significantly reduced in the IgA
plasma cells of the duodenal lamina propria in patients with
IgAN (median 54% positive) compared to controls, whereas the
expression of kappa light chain mRNA was not, indicating that
the observed down-regulation of J chain mRNA expression in
duodenal IgA plasma cells in IgAN is specific for immunoglob-
ulin J chain.
The most important marker of high level pIg secretion
appears to be the levels of J chain mRNA [32]. Our findings
therefore suggest that within the duodenal IgA plasma cells in
IgAN there is a lower J chain mRNA copy number, reduced
synthesis of J chain and a shift away from pIgA production and
secretion. These data highlight a possible defect of IgA secre-
tory immunity in IgAN, since specific mucosal defence is
afforded by external transcellular transport of pigA [52]. They
also suggest in contrast to our initial hypothesis, that the lamina
propria is unlikely to be the source of excess circulating IgA or
deposited glomerular IgA in this condition.
The lamina propria abnormalities we have described could be
secondary to the up-regulation of J chain expression and pIgA
production at some other site, for example the tonsils or bone
marrow. Both these tissues have been shown to contain greater
numbers of IgA immunocytes in patients with IgAN compared
to controls [21—25].
Alternatively, our findings may point to a fundamental flaw in
mucosal immunity in IgAN, giving rise to a primary defect in
mucosal antigen handling in this condition. Such a defect would
reduce antigen exclusion and IgA-immune complex clearance
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[53], allowing undue antigen penetration into lamina propria and
ultimately the circulation. The systemic immune system would
then be subject to a prolonged and excessive stimulation by
antigens which under normal circumstances are excluded. The
resulting immunoglobulin or immunoglobulin-antigen com-
plexes would become potential species for glomerular deposi-
tion. This proposition is supported by many studies reporting
increased circulating immune complexes in IgAN, frequently
correlating with disease activity as defined by hematuria [9, 13,
54].
It has been suggested that the pattern of abnormalities we
have demonstrated (reduced J chain but increased IgG expres-
sion) is associated with a general abrogation of oral tolerance
[55]. Oral or mucosal tolerance is the T cell governed process
which enables systemic (IgG) tolerance and mucosal (IgA)
immunity to a luminal antigen to exist simultaneously [56].
There is experimental evidence from certain murine models of
IgAN to support the link between defective IgA mucosal
antigen handling, systemic IgG intolerance and glomerular
immune deposits [57—59]. Although basic species differences in
normal IgA immunology require animal models to be inter-
preted with caution, the present study provides evidence of a
comparable defect in mucosal immunoregulation in IgAN in
humans.
An early immunofluorescence study of the duodenal mucosa
of only five patients with IgAN failed to demonstrate a signifi-
cant difference in numbers of IgA, IgG or 1gM cells [60]. Our
immunofluorescence results confirm data of a later study which
demonstrated that within the lamina propna in IgAN, the
proportion of IgA cells is reduced and IgG cells increased [20].
Our study revealed a 5% reduction in IgA plasma cells and a
near doubling of absolute numbers of IgG cells. This would
equate to an increase in IgG cells of from 3 to 6% of total.
Although this suggests a small reduction in the number of
plasma cells in the lamina propria of patients, this was certainly
not evident microscopically in our study or in that of Hene,
Schuurman and Kater, in which the reduction of IgA plasma
cells was mirrored by an equivalent increase in IgG and 1gM
cells [201.
Our initial ISH protocol revealed a significant difference
between the proportion of plasmacytoid cells that express J
chain mRNA in patients and controls. The proportion of J chain
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propria component of the mucosal IgA system is not the source
of glomerular pIgA in this condition, and that further investi-
gation of IgA immunocyte J chain mRNA expression in both
tonsil and marrow is required.
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